CTP 347

Drug Profile

CTP 347

Alternative Names: CTP-347

Latest Information Update: 25 Jun 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Concert Pharmaceuticals
  • Class Organic deuterium compounds; Piperidines; Small molecules
  • Mechanism of Action Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Hot flashes

Most Recent Events

  • 25 Jun 2013 Discontinued - Phase-I for Hot flashes in USA prior to 25 June 2013 (PO)
  • 14 Sep 2009 Final pharmacokinetics data from a phase I trial in Hot flashes released by Concert Pharmaceuticals
  • 16 Mar 2009 Interim pharmacokinetics and safety data from a phase I trial in healthy volunteers released by Concert Pharmaceuticals
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top